Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to boost Pill-Taking in hypertension patients

NCT ID NCT05131074

Disease control Sponsor: Anjali Raja Beharelle Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app called Collabree to see if it helps people over 50 with high blood pressure take their medication more regularly. 144 participants used the app for 90 days and were followed for another 90 days. The app sent reminders and used behavioral tricks to encourage adherence. Researchers measured pill counts and self-reports to see if the app made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Collabree mobile phone application (behavioral intervention)
What this could lead to
If successful, this app could help people with high blood pressure take their medication more consistently, improving blood pressure control and reducing health risks.
What could go wrong
This is a small, completed study with 144 participants. The app may not work for everyone, and results might not apply to people who don't use smartphones or have different medication routines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

144 people

The number who actually took part.

Started

Mar 2022

Finished

Nov 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Informed consent as documented by signature. 2. Over 50 years of age on date of randomization. 3. Patient received prescription medicine against hypertension by post from MediService. 4. Prescribed a therapy against hypertension consisting of 4 or more tablets taken per day. At least 1 dose of medication per day must be against hypertension. 5. Participant administers their own medications. 6. Participant owns a smartphone with a data plan or constant internet access during the study reporting events and at home to use the application. 7. Minimal required smartphone operating system is iOS 12 and Android 8 (Oreo). 8. Adequate communication in German or Swiss-German (all study documentation will only be set to the German language). Exclusion Criteria: 1. Inability to operate a mobile phone and the Collabree application. 2. Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. 3. Enrollment of the Sponsor-Investigator, their family members, employees, and other dependent persons. 4. Participation in another interventional clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension Medication adherence

Contacts and locations

Locations

  • Collabree AG

    Zurich, Canton of Zurich, 8002, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.